Stock 300142 WALVAX BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Walvax Biotechnology Co., Ltd.

Equities

300142

CNE100000WN2

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
14.71 CNY -0.88% Intraday chart for Walvax Biotechnology Co., Ltd. +2.94% -37.43%
04-26 Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 MT
04-25 Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial MT

Business Summary

Walvax Biotechnology Co. specialises in the research, development, manufacturing and marketing of human vaccines. Products include vaccines against haemophilus influenzae, meningitis, septicaemia, meningococcal disease, etc.

Number of employees: 2,388

Sales per Business

CNY in Million2022Weight2023Weight Delta
Autonomous Vaccine
99.1 %
- - 4,078 99.1 % -
Intermediate Products
0.4 %
27 0.5 % 17 0.4 % -36.61%
Technical Services
0.3 %
17 0.3 % 11 0.3 % -33.40%
Other Business
0.2 %
8 0.2 % 8 0.2 % +3.51%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
93.0 %
4,803 94.4 % 3,826 93.0 % -20.34%
Overseas
7.0 %
283 5.6 % 288 7.0 % +1.46%

Managers

Managers TitleAgeSince
Run Sheng Jiang PSD
 President 67 21/06/16
Hua Zhou DFI
 Director of Finance/CFO 57 22/06/14
Shao zhong Dong BRD
 Director/Board Member 56 26/01/22
Jian Kang Zhang BRD
 Director/Board Member 67 28/05/20
Zhen Huang BRD
 Director/Board Member 61 31/12/02
Yu Ran Liu SEC
 Corporate Secretary 35 09/11/22

Members of the board

Members of the board TitleAgeSince
Ling Bing Zeng BRD
 Director/Board Member 67 12/10/22
Zhen Huang BRD
 Director/Board Member 61 31/12/02
Yun Chun Li CHM
 Chairman 62 22/06/09
Jin Yu Zhu BRD
 Director/Board Member 57 22/06/09
Run Sheng Jiang PSD
 President 67 21/06/16
Gang Hong Sun BRD
 Director/Board Member 55 12/10/22
Shao zhong Dong BRD
 Director/Board Member 56 26/01/22
Jian Mei Zhao BRD
 Director/Board Member 55 11/10/20
Ji Shi BRD
 Director/Board Member 30 11/08/19
Ting Yan BRD
 Director/Board Member 37 23/11/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,615,348,427 442,894,341 ( 27.42 %) 7,999,943 ( 0.4952 %) 27.42 %

Shareholders

NameEquities%Valuation
Jun Hui Liu
3.476 %
54,161,648 3.476 % 115 M ¥
E Fund Management Co., Ltd.
3.078 %
47,952,788 3.078 % 102 M ¥
China Merchants Fund Management Co., Ltd.
2.182 %
33,999,449 2.182 % 72 M ¥
Geng Yang
1.945 %
30,305,900 1.945 % 64 M ¥
Yun Chun Li
1.743 %
27,150,181 1.743 % 58 M ¥
Qing Hui Wang
1.556 %
24,240,000 1.556 % 52 M ¥
Wangxi Tech District Group Real Estate Devt Co. Ltd.
1.543 %
24,038,398 1.543 % 51 M ¥
Chengdu Xiyun Enterprise Management LP
1.518 %
23,656,807 1.518 % 50 M ¥
Jing Huang
1.517 %
23,629,589 1.517 % 50 M ¥
Er Jia Chen
1.462 %
22,784,277 1.462 % 48 M ¥
NameEquities%Valuation
Yun Chun Li
43.09 %
20,362,636 43.09 % 43 M ¥
Zhen Huang
28.09 %
13,274,047 28.09 % 28 M ¥
Run Sheng Jiang
1.637 %
773,437 1.637 % 2 M ¥
Wei Yao
1.627 %
768,750 1.627 % 2 M ¥
Yun Yan Wu
1.627 %
768,750 1.627 % 2 M ¥
Sun Qing Gong
1.536 %
725,857 1.536 % 2 M ¥
Jin Long Zhao
1.535 %
725,531 1.535 % 2 M ¥
Hua Zhou
1.428 %
675,000 1.428 % 1 M ¥
Jing Shi
1.131 %
534,375 1.131 % 1 M ¥
Lin Yuan
1.131 %
534,375 1.131 % 1 M ¥

Holdings

NameEquities%Valuation
WALVAX BIOTECHNOLOGY CO., LTD.
0.64%
 9,999,943 0.64% 21,279,879 $
GENOR BIOPHARMA HOLDINGS LIMITED
7.40%
 37,560,998 7.40% 5,951,165 $

Company contact information

Walvax Biotechnology Co., Ltd.

395, Kexin Road High-tech Zone

650101, Kunming

+86 87 1683 30860

http://www.walvax.com
address Walvax Biotechnology Co., Ltd.(300142)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Walvax Biotechnology Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
14.71 CNY
Average target price
20 CNY
Spread / Average Target
+35.96%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
WALVAX BIOTECHNOLOGY CO., LTD. Stock Walvax Biotechnology Co., Ltd.
-37.43% 3.25B
CSL LIMITED Stock CSL Limited
-4.24% 86.85B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 40.16B
BIOGEN INC. Stock Biogen Inc.
-16.43% 31.28B
UCB Stock UCB
+57.86% 25.27B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-15.95% 15.33B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.12% 11.96B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.56% 11.61B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+6.89% 8.83B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-10.53% 7.94B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 300142 Stock
  4. Company Walvax Biotechnology Co., Ltd.